Answers are grounded in this paper and cite their sources.
Experimental study reveals annealing temperature controls recrystallization and tensile trade-offs in cold-rolled L-605 alloy, indicating optimal thermal pathways for biomedical implants.
This work investigated the effects of annealing temperature and holding time on recrystallization, grain growth, and tensile properties of cold-rolled biomedical Co–20Cr–15W–10Ni (L-605) alloy. The alloy was solution-treated at 1200 °C for 30 min, cold-rolled to 40% area reduction, and annealed at 800–950 °C for 15 min, 1000 °C for 5–60 min, or 1200 °C for 5–60 min. Annealing at 800–900 °C produced partially recrystallized microstructures; 950 °C yielded nearly full recrystallization with an average grain size of ~3.4 μm. At 1000 °C, the fully recrystallized microstructure retained ~5 μm fine grains even after 60 min, likely due to grain boundary migration inhibition by fine secondary-phase particles, whose composition and pinning effect remain unclarified. At 1200 °C, grains grew significantly to ~90 μm, attributed to higher grain boundary mobility and reduced particle pinning at elevated temperature. As annealing temperature rose from 800 °C to 950 °C, yield strength decreased from 1245 MPa to 800 MPa, and elongation increased from 12.6% to 45.9%. At 1200 °C, yield strength fell to 442–455 MPa and elongation reached 73.5–80.8%. The results confirm that the alloy’s strength–ductility performance is directly determined by microstructure evolution from retained cold rolling deformation substructures to fine recrystallized grains, and further to coarse recrystallized grains at higher temperatures.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: